Patient Square Capital LP Roivant Sciences Ltd. Transaction History
Patient Square Capital LP
- $242 Billion
- Q1 2025
A detailed history of Patient Square Capital LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Patient Square Capital LP holds 12,480,000 shares of ROIV stock, worth $144 Million. This represents 52.09% of its overall portfolio holdings.
Number of Shares
12,480,000
Previous 12,480,000
-0.0%
Holding current value
$144 Million
Previous $148 Billion
14.71%
% of portfolio
52.09%
Previous 55.22%
Shares
4 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
496MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$759 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$714 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$531 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$470 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$415 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.13B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...